advertisement

---

Leal S 16

Showing records 1 to 16 | Display all abstracts from Leal S

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Inatani M
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Inatani M; Higashide T
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Higashide T; Matsushita K
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Matsushita K
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Miki A
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Nagasato D; Takagi H
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Ueki M
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Ueki M
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Iwamoto Y; Kobayashi M
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Takai Y
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Leal S
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Miyazaki K
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Leal S
Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Iwamoto Y
Advances in Therapy 2021; 38: 1106-1115

---

91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial

Advances in Therapy 2021; 38: 1116-1129

---

91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Kobayashi M; Leal S; Leal S
Advances in Therapy 2021; 38: 1106-1115

---